Stock Scorecard
Stock Summary for Evolus Inc (EOLS) - $7.52 as of 8/29/2025 3:20:44 PM EST
Total Score
8 out of 30
Safety Score
31 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EOLS
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EOLS
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EOLS
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EOLS
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for EOLS (31 out of 100)
Stock Price Rating (Max of 10) | 4 |
Historical Stock Price Rating (Max of 10) | 4 |
Stock Price Trend (Max of 10) | 9 |
Book Value (Max of 10) | 1 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 4 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 5 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for EOLS
Financial Details for EOLS
Company Overview |
|
---|---|
Ticker | EOLS |
Company Name | Evolus Inc |
Country | USA |
Description | Evolus, Inc., a high-performance beauty company, provides aesthetic medical products for physicians and their patients in the United States. The company is headquartered in Newport Beach, California. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 6/30/2025 |
Next Earnings Date | 11/11/2025 |
Stock Price History |
|
Last Day Price | 7.52 |
Price 4 Years Ago | 6.51 |
Last Day Price Updated | 8/29/2025 3:20:44 PM EST |
Last Day Volume | 472,060 |
Average Daily Volume | 1,866,543 |
52-Week High | 17.82 |
52-Week Low | 5.71 |
Last Price to 52 Week Low | 31.70% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 40.47 |
Sector PE | 60.89 |
5-Year Average PE | -18.69 |
Free Cash Flow Ratio | 7.92 |
Industry Free Cash Flow Ratio | 15.46 |
Sector Free Cash Flow Ratio | 30.76 |
Current Ratio Most Recent Quarter | 2.27 |
Total Cash Per Share | 0.95 |
Book Value Per Share Most Recent Quarter | -0.29 |
Price to Book Ratio | 53.71 |
Industry Price to Book Ratio | 28.68 |
Sector Price to Book Ratio | 26.74 |
Price to Sales Ratio Twelve Trailing Months | 1.78 |
Industry Price to Sales Ratio Twelve Trailing Months | 25.19 |
Sector Price to Sales Ratio Twelve Trailing Months | 13.32 |
Analyst Buy Ratings | 4 |
Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
Total Shares Outstanding | 64,685,000 |
Market Capitalization | 486,431,200 |
Institutional Ownership | 91.21% |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 18.26% |
Reported EPS 12 Trailing Months | -0.97 |
Reported EPS Past Year | -0.44 |
Reported EPS Prior Year | -0.28 |
Net Income Twelve Trailing Months | -61,995,000 |
Net Income Past Year | -50,420,000 |
Net Income Prior Year | -61,685,000 |
Quarterly Revenue Growth YOY | 3.70% |
5-Year Revenue Growth | 50.12% |
Operating Margin Twelve Trailing Months | -20.40% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 61,738,000 |
Total Cash Past Year | 86,952,000 |
Total Cash Prior Year | 62,838,000 |
Net Cash Position Most Recent Quarter | -83,737,000 |
Net Cash Position Past Year | -34,554,000 |
Long Term Debt Past Year | 121,506,000 |
Long Term Debt Prior Year | 120,359,000 |
Total Debt Most Recent Quarter | 145,475,000 |
Equity to Debt Ratio Past Year | 0.04 |
Equity to Debt Ratio Most Recent Quarter | -0.15 |
Total Stockholder Equity Past Year | 5,522,000 |
Total Stockholder Equity Prior Year | -20,689,000 |
Total Stockholder Equity Most Recent Quarter | -18,652,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -46,302,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.72 |
Free Cash Flow Past Year | -19,471,000 |
Free Cash Flow Prior Year | -35,635,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.31 |
MACD Signal | -0.49 |
20-Day Bollinger Lower Band | 6.42 |
20-Day Bollinger Middle Band | 9.29 |
20-Day Bollinger Upper Band | 12.15 |
Beta | 1.12 |
RSI | 48.65 |
50-Day SMA | 12.00 |
150-Day SMA | 10.80 |
200-Day SMA | 10.48 |
System |
|
Modified | 8/29/2025 10:53:40 PM EST |